Ikpatt Francis, Kuopio Teijo, Erekul Aras, Collan Yrjö
Department of Pathology, University of Calabar Teaching Hospital, Nigeria.
Anal Quant Cytol Histol. 2002 Apr;24(2):73-80.
To evaluate apoptotic activity in breast cancer from Nigerian (n = 300) and Finnish (n=285) women.
Apoptotic bodies were expressed as square millimeters of neoplastic tissue (apoptotic index [AI]). The standardized mitotic index (SMI) and mitotic activity index (MAI) estimated proliferation.
The mean (+/- SD) AI was higher in Nigeria (9.6+/-14.8/mm2) than in Finland (5.2+/-6.1/ mm2). In both populations, AI values were higher in premenopausal than postmenopausal women, in lymph node positive than lymph node negative tumors and in larger than smaller tumors. However, the differences were not statistically significant. Increasing histologic grade was associated with increasing AI values (Nigeria, P =.012; Finland, P= .0001). AI in infiltrating ductal carcinomas were higher than in special types of breast cancer (Nigeria, P = .0700; Finland, P = .0168). As a continuous variable, AI was a significant prognosticator (Nigeria, P = .0125, Finland, P = .0466). Increasing AI appeared to be associated with tumor progression and dedifferentiation. The higher SMI/AI in Nigeria (9.2) than in Finland (4.5) reflects higher proliferative activity in the Nigerian material. In multivariate analysis of AI, SMI, MAI and tumor size, the proliferative indices (SMI and MAI) and tumor size only were significant independent prognosticators.
In Nigerian and Finnish material, AI has limited prognostic value as a tool in grading breast cancer. The higher mean SMI/AI in Nigerian cancer suggests a shift in the proliferation/cell death balance, which may be associated with a later phase of the cancer progression cascade.
评估尼日利亚(n = 300)和芬兰(n = 285)女性乳腺癌中的凋亡活性。
凋亡小体以肿瘤组织的平方毫米表示(凋亡指数[AI])。标准化有丝分裂指数(SMI)和有丝分裂活性指数(MAI)评估增殖情况。
尼日利亚的平均(±标准差)AI(9.6±14.8/mm²)高于芬兰(5.2±6.1/mm²)。在这两个人群中,绝经前女性的AI值高于绝经后女性,淋巴结阳性肿瘤的AI值高于淋巴结阴性肿瘤,较大肿瘤的AI值高于较小肿瘤。然而,这些差异无统计学意义。组织学分级增加与AI值增加相关(尼日利亚,P = 0.012;芬兰,P = 0.0001)。浸润性导管癌的AI高于特殊类型的乳腺癌(尼日利亚,P = 0.0700;芬兰,P = 0.0168)。作为连续变量,AI是一个显著的预后指标(尼日利亚,P = 0.0125,芬兰,P = 0.0466)。AI增加似乎与肿瘤进展和去分化有关。尼日利亚的SMI/AI(9.2)高于芬兰(4.5),反映了尼日利亚材料中较高的增殖活性。在对AI、SMI、MAI和肿瘤大小进行多变量分析时,增殖指数(SMI和MAI)和肿瘤大小仅是显著的独立预后指标。
在尼日利亚和芬兰的材料中,AI作为乳腺癌分级工具的预后价值有限。尼日利亚癌症中较高的平均SMI/AI表明增殖/细胞死亡平衡发生了变化,这可能与癌症进展级联的后期阶段有关。